| Stage | LHX | % of rev | FANG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.1B | 100.00% | $5.6B | 100.00% | LHX ×1.09 |
| Gross profit | $1.6B | 26.60% | $4.7B | 84.84% | FANG +58.2pp |
| Operating income | $786M | 12.97% | $2.5B | 45.16% | FANG +32.2pp |
| Pre-tax income | $743M | 12.26% | $2.6B | 47.38% | FANG +35.1pp |
| Net income | $632M | 10.43% | $2.1B | 36.95% | FANG +26.5pp |
| Stage | LHX | FANG | Gap · A − B |
|---|---|---|---|
| Revenue | $6.1B100.00% | $5.6B100.00% | LHX ×1.09 |
| Gross profit | 26.60%$1.6B | 84.84%$4.7B | FANG +58.2pp |
| Operating income | 12.97%$786M | 45.16%$2.5B | FANG +32.2pp |
| Pre-tax income | 12.26%$743M | 47.38%$2.6B | FANG +35.1pp |
| Net income |
| 10.43%$632M |
| 36.95%$2.1B |
| FANG +26.5pp |
No shared counterparties.